Guggenheim Reiterates Buy on Aralez Pharma (ARLZ) Following Yosprala Approval
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
- Dow, S&P inch up as AmEx gains; Netflix slump drags down Nasdaq
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Wall St indexes split, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Jabil falls after placing CEO on paid leave amid internal investigation
- Netflix, Tesla, Amex, P&G fall premarket; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Aralez Pharma (ARLZ) Halted on LUDP
September 15, 2016 10:00 AM EDTAralez Pharma (NASDAQ: ARLZ) Halted on LUDP
... MoreAralez Pharma (ARLZ) will resume trading at 10:00am ET
September 15, 2016 9:44 AM EDTAralez Pharma (NASDAQ: ARLZ) will resume trading at 10:00am EDT.
... MoreAralez Pharma (ARLZ) Announces FDA Approval for YOSPRALA
September 15, 2016 9:35 AM EDTAralez Pharmaceuticals Inc. (NASDAQ: ARLZ) announced today that the U.S. Food and Drug Administration (FDA) has approved once-daily YOSPRALA, the only prescription fixed-dose combination of aspirin, an anti-platelet agent, and omeprazole, a proton pump inhibitor (PPI) in the U.S. YOSPRALA is indicated for patients who require aspirin for secondary prevention of cardiovascular (CV) and cerebrovascular events and who are at risk of developing aspirin associated gastric ulcers. The Company is expanding its U.S. sales force by 85... More
Aralez Pharma (ARLZ) trading halted with news pending
September 15, 2016 7:01 AM EDTAralez Pharma (NASDAQ: ARLZ) trading halted with news pending.
... MoreAralez Pharma (ARLZ) Slammed, Halted Ahead of PDUFA Date
September 14, 2016 11:40 AM EDTAralez Pharma (NASDAQ: ARLZ) has resumed trading and is down 14%. Today is the company's PDUFA date for YOSPRALA.
... MoreAralez Pharma (ARLZ) Halted on LUDP
September 14, 2016 11:36 AM EDTAralez Pharma (NASDAQ: ARLZ) Halted on LUDP
... More
